Planet Labs PBC (PL) financials
NYSE · Industrials · Aerospace & Defense · 973 employees · CEO William Spencer Marshall
- Price
- $10.72
- Market cap
- $3.58B
- Enterprise value
- $3.62B Data as of 2026-11-21
- Last report
- Q2 '27 filed 2026-09-03
- Next report
- 2026-12-10 EPS est. -$0.03
Valuation & key figures
- Market cap
- $3.58B Updated 1h ago
- Revenue
- $378M Trailing 12 months
- Revenue growth
- +42% FY2027 consensus
- Profit margin
- -95.1% Net income / revenue, TTM
- P/E
- No P/E Loss in the last twelve months
- P/S
- 9.5× Price / sales, TTM
- EV / EBITDA
- -11.8× TTM
- Free cash flow
- $23.4M Trailing 12 months
- Net income
- -$360M Trailing 12 months
- Revenue estimate
- $438M FY2027 consensus
- Earnings
- 2026-12-10 Revenue est. $104M · Updated 1h ago
- Dividend
- – No dividend
Key takeaways
Computed from the reported numbers - every statement carries the figure it rests on.
- Last report (2026-09-03): revenue beat by 11.0%, EPS beat by 205.1%Revenue $116M vs $105M expected (+11.0%); EPS $0.02 vs -$0.02 (+205.1%).
- Revenue growth accelerating: 58.1% year on yearQ2 '27 revenue $116M, against an average of 34.0% over the four quarters before.
- Operating margin -27.2% (TTM), +4.4 pp on a year agoOperating income grew -24.2% while revenue grew 44.1%.
- Capex 24.9% of revenue (a year ago 19.3%)$94.2M invested in the last 4 quarters (+86.4% on a year earlier). Free cash flow $23.4M.
- Diluted share count up 18.2% in a year360M diluted shares in Q2 '27, 304M a year earlier.
- Net cash $417MCash + short-term investments $865M, debt incl. leases $448M; a year ago net cash $260M.
Last quarter: Q2 '27
Quarter ended 2026-07-31. Compared with the same quarter a year earlier and with the analyst consensus before the report.
Quarter vs a year ago
| Q2 '27 | Year ago | Change | |
|---|---|---|---|
| Revenue | $116M | $73.4M | +58.1% |
| Gross margin | 56.6% | 57.6% | -1.0 pp |
| Operating income | -$13.5M | -$18M | +24.8% |
| Operating margin | -11.6% | -24.5% | +12.8 pp |
| Net income | -$9.35M | -$22.6M | +58.6% |
| Diluted EPS | -$0.03 | -$0.07 | +59.6% |
| Operating cash flow | $52.9M | $67.8M | -21.9% |
| Capex | $27.3M | $18.4M | +48.3% |
| Free cash flow | $25.6M | $49.3M | -48.1% |
| R&D | $35.2M | $24.2M | +45.5% |
| Stock-based compensation | $17.1M | $13.5M | +26.8% |
Reported vs consensus
2026-09-03| Actual | Consensus | vs consensus | |
|---|---|---|---|
| Revenue | $116M | $105M | +11.0% |
| EPS (as estimated) | $0.02 | -$0.02 | +205.1% |
From the report of 2026-09-03 for Q2 '27: revenue and the EPS analysts estimate (often adjusted), so it can differ from the EPS of the statements above.
EPS vs consensus
last 8 reportsRevenue
Where the money comes from - by business line and by region, quarter by quarter.
Revenue, operating income and growth
quarterlyRevenue by business line
stacked, quarterly| Segment | Q2 '26 | y/y | Share of listed | TTM | TTM y/y | 12 quarters |
|---|---|---|---|---|---|---|
| Reportable Segment | $73.4M | – | 100.0% | – | – |
Revenue by region
share of the listed regions| Segment | Q2 '27 | y/y | Share of listed | TTM | TTM y/y | 12 quarters |
|---|---|---|---|---|---|---|
| EMEA | $55.2M | +135.2% | 47.6% | – | – | |
| North America | $39M | +25.5% | 33.6% | – | – | |
| Asia Pacific And Japan | $19.1M | +18.2% | 16.5% | – | – | |
| Latin America | $2.74M | +2.5% | 2.4% | – | – |
Margins & cost structure
How much of each unit of revenue is left at each level - and where the costs go.
Margins
quarterlyCosts as % of revenue
quarterlyCash flow & capital allocation
Cash generated, what it is spent on, and what reaches shareholders.
Operating cash flow, capex, free cash flow
quarterlyUses of cash vs operating cash flow
fiscal yearsLast 4 quarters
cash flow statement- Operating cash flow
- $118M
- Capex
- -$94.2M
- Buybacks
- $86.1M
- Dividends
- $0
- Acquisitions
- -$1.35M
- Net debt issued
- $406M
- Stock-based compensation
- $62.5M
- Free cash flow
- $23.4M
- Returned to shareholders / FCF
- -367.3%
Share count and EPS
quarterly, dilutedBalance sheet
Liquidity, investments and debt at each quarter end.
Cash, investments and debt
quarter endsValuation & returns
Today's multiples against the company's own last five fiscal years; analyst targets and ratings.
Multiples and returns
TTM vs 5 fiscal years| Now | 5y average | Where today sits in the 5-year range | |
|---|---|---|---|
| P/E (TTM) | – | – | – |
| EV / EBITDA | -11.8× | – | – |
| EV / Sales | 9.6× | 9.9× | 2.6× – 25.7× |
| Price / FCF | 153.0× | 133.3× 1 of 5 years | 133.3× – 133.3× |
| Price / Book | 6.7× | 10.2× | 1.2× – 40.8× |
| FCF yield | 0.7% | -5.5% | -14.7% – 0.8% |
| Return on invested capital | -9.5% | -22.6% | -29.6% – -13.9% |
| Return on equity | -93.1% | -47.1% | -131.0% – -21.2% |
Analysts
Consensus target $28.63 (+171.9%)
range $17.00 – $40.00 · rating Buy
Outlook
Analyst consensus for the coming fiscal years and what it implies at today's price.
Consensus estimates
| Fiscal year | Revenue | Growth | EPS | Growth | P/E at today's price | Analysts (EPS) |
|---|---|---|---|---|---|---|
| FY2027 | $438M | +42.2% | -$0.05 | +94.1% | – | 5 |
| FY2028 | $571M | +30.6% | $0.01 | +129.9% | 766.3× | 6 |
| FY2029 | $736M | +28.8% | $0.14 | +902.4% | 76.5× | 3 |
| FY2030 | $843M | +14.6% | $0.25 | +78.3% | 42.9× | 1 |
Financial statements
Every line of the income statement, balance sheet and cash flow statement - 12 quarters and 10 fiscal years, as values, as % of revenue or as growth.
Every reported line
All 249 figures Planet Labs PBC tagged in its recent 10-Q / 10-K filings, with the official SEC label and definition - including the notes (leases, taxes, buybacks, employees, ...).
| Line (SEC label) | Latest quarter | Year ago | y/y | Latest FY | Prior FY | y/y |
|---|---|---|---|---|---|---|
| Accounts Payable, Current | $10.4M | $11.1M | -6.3% | $10.6M | $2.6M | +307.5% |
| Accounts Receivable, after Allowance for Credit Loss, Current | $59.9M | $51.6M | +16.0% | $83.5M | $55.8M | +49.6% |
| Accounts Receivable, Allowance for Credit Loss, Current | $0 | $396K | -100.0% | $3 | $807 | -99.6% |
| Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment | $234M | $258M | -9.5% | $238M | $247M | -3.6% |
| Accumulated Other Comprehensive Income (Loss), Net of Tax | $3.37M | $3.85M | -12.5% | $6.36M | -$1.1M | +679.9% |
| Additional Paid in Capital | $2.16B | $1.67B | +29.3% | $1.63B | $1.65B | -0.8% |
| Amortization of Intangible Assets | $1.8M | $1.5M | +20.0% | $5.9M | $5.8M | +1.7% |
| Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | -3.83M | -5.37M | +28.7% | 102M | 96.1M | +5.9% |
| APIC, Share-based Payment Arrangement, Increase for Cost Recognition | $18M | $14.1M | +27.3% | $57.6M | $50.8M | +13.3% |
| Asset Impairment Charges | – | – | – | $0 | $0 | – |
| AssetAcquisitionContingentConsiderationLiability | $02026-01-31 | $4.68M | -100.0% | $0 | $4.68M | -100.0% |
| Assets | $1.43B | $696M | +105.5% | $1.15B | $634M | +80.8% |
| Assets, Current | $999M | $355M | +181.0% | $775M | $302M | +156.6% |
| Business Combination, Consideration Transferred, Liabilities Incurred | – | – | – | $0 | $0 | – |
| Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability | $0 | $717K | -100.0% | $465K | $3.44M | -86.5% |
| Business Combination, Contingent Consideration, Liability, Current | $1.21M2025-10-31 | $4.41M | -72.6% | $4.7M2025-01-31 | $7.01M | -32.9% |
| Business Combination, Contingent Consideration, Liability, Noncurrent | $02026-01-31 | $2.88M | -100.0% | $0 | $2.88M | -100.0% |
| Capital Expenditures Incurred but Not yet Paid | – | – | – | $5.02M | $718K | +599.0% |
| Capitalized Computer Software, Accumulated Amortization | $38.6M | $34M | +13.5% | $36M | $32.6M | +10.6% |
| Capitalized Computer Software, Amortization | $1.3M | $700K | +85.7% | $3.4M | $2.5M | +36.0% |
| Capitalized Computer Software, Gross | $60.6M | $54.6M | +11.1% | $57.5M | $51.5M | +11.6% |
| Capitalized Computer Software, Net | $22.1M | $20.6M | +7.2% | $21.5M | $19M | +13.2% |
| Capitalized Contract Cost, Amortization | $500K | $500K | 0.0% | $2.1M | $2.9M | -27.6% |
| Capitalized Contract Cost, Net | $3.9M | $3.63M | +7.4% | $4.32M | $3.7M | +16.7% |
| Capitalized Contract Cost, Net, Current | $2.2M | $1.65M | +33.6% | $1.91M | $1.98M | -3.5% |
| Capitalized Contract Cost, Net, Noncurrent | $1.7M | $1.99M | -14.4% | $2.41M | $1.72M | +40.0% |
| Cash and Cash Equivalents, at Carrying Value | $415M | $181M | +129.2% | $229M | $118M | +94.4% |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | $424M | $193M | +119.6% | $236M | $130M | +81.2% |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | $48M | $47.3M | +1.5% | $106M | $27.8M | +279.8% |
| Class of Warrant or Right, Exercise Price of Warrants or Rights | $9.38 | – | – | $9.38 | $9.38 | 0.0% |
| Class of Warrant or Right, Outstanding | 1.07M | – | – | 1.07M | 1.07M | 0.0% |
| Common Stock, Par or Stated Value Per Share | $0.00 | $0.00 | 0.0% | $0.00 | $0.00 | 0.0% |
| Common Stock, Value, Issued | $36K | $28K | +28.6% | $34K | $28K | +21.4% |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent | -$10.9M | -$22.4M | +51.4% | -$239M | -$126M | -90.2% |
| Concentration Risk, Credit Risk, Financial Instrument, Maximum Exposure | $133M | $45.5M | +192.7% | $638M | $220M | +190.2% |
| Contract with Customer, Liability, Current | $281M | $148M | +90.0% | $221M | $82.3M | +168.1% |
| Contract with Customer, Liability, Noncurrent | $17.4M | $25M | -30.6% | $27.5M | $11.2M | +146.1% |
| Contract with Customer, Liability, Revenue Recognized | $62.8M | $26M | +141.5% | $79.4M | $68.8M | +15.4% |
| Convertible Notes Payable | $448M | – | – | $447M | $0 | – |
| Cost of Goods and Services Sold | $50.4M | $31.1M | +62.0% | $135M | $105M | +29.3% |
| Current Federal Tax Expense (Benefit) | – | – | – | $37K | $0 | – |
| Current Foreign Tax Expense (Benefit) | – | – | – | $4.52M | $2.31M | +95.8% |
| Current Income Tax Expense (Benefit) | – | – | – | $4.6M | $2.36M | +94.7% |
| Current State and Local Tax Expense (Benefit) | – | – | – | $43K | $54K | -20.4% |
| Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax | $33K | $73K | -54.8% | $434K | $215K | +101.9% |
| Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax | $778K | $48K | +1,520.8% | $19K | $74K | -74.3% |
| Debt Securities, Available-for-sale, Amortized Cost, Current | $451M | $90.4M | +398.8% | $410M | $104M | +294.9% |
| Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One | $260M | $31M | +739.7% | $270M | $61M | +343.4% |
| Debt Securities, Available-for-sale, Current | $450M | $90.5M | +397.8% | $411M | $104M | +294.8% |
| Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One | $260M | $31M | +738.0% | $271M | $61.2M | +342.3% |
| Deferred Federal Income Tax Expense (Benefit) | – | – | – | $197K | -$642K | +130.7% |
| Deferred Foreign Income Tax Expense (Benefit) | – | – | – | $3K | $25K | -88.0% |
| Deferred Income Tax Expense (Benefit) | – | – | – | $56K | $98K | -42.9% |
| Deferred State and Local Income Tax Expense (Benefit) | – | – | – | -$144K | $715K | -120.1% |
| Deferred Tax Assets, Gross | $358M2026-01-31 | $297M | +20.4% | $358M | $297M | +20.4% |
| Deferred Tax Assets, in Process Research and Development | $20.8M2026-01-31 | $67M | -69.0% | $20.8M | $67M | -69.0% |
| Deferred Tax Assets, Net of Valuation Allowance | $12.2M2026-01-31 | $12.4M | -1.2% | $12.2M | $12.4M | -1.2% |
| Deferred Tax Assets, Operating Loss Carryforwards | $241M2026-01-31 | $143M | +68.6% | $241M | $143M | +68.6% |
| Deferred Tax Assets, Other | $9.09M2026-01-31 | $5.68M | +60.0% | $9.09M | $5.68M | +60.0% |
| Deferred Tax Assets, Property, Plant and Equipment | $16.3M2026-01-31 | $19.2M | -15.4% | $16.3M | $19.2M | -15.4% |
Source: SEC companyfacts (XBRL of every 10-Q / 10-K). Cash-flow quarters are derived from the year-to-date figures the 10-Q tags. Segment breakdowns are tagged with dimensions and are shown in the segment section instead.
Sources
Statements, segment revenue, metrics and estimates are standardised from the company's filings. Segment profits and every reported line: SEC EDGAR (XBRL). Filings read: 10-Q 2026-07-31, 10-Q 2026-04-30, 10-K 2026-01-31, 10-Q 2025-10-31, 10-Q 2025-07-31, 10-Q 2025-04-30, 10-K 2025-01-31, 10-Q 2024-10-31, 10-Q 2024-07-31
Data as of 2026-11-21